5 Dividend Stocks to Buy Now According to Kerr Neilson’s Hedge Fund

1. Gilead Sciences, Inc. (NASDAQ:GILD)

Stake Value of Platinum Asset Management: $81,347,000

Percentage of Platinum Asset Management’s 13F Portfolio: 2.26%

Dividend Yield as of April 12: 4.72%

Number of Hedge Fund Holders: 54

Gilead Sciences, Inc. (NASDAQ:GILD) operates as a biopharmaceutical company in the United States, Europe, and internationally. As of April 12, 2022, Gilead Sciences, Inc. (NASDAQ:GILD) has a forward yield of 4.72%, an annual dividend payout ratio of 38.96%, and boasts a 5-year dividend growth rate of 8.18%

This February, the company reported earnings for the fiscal fourth quarter of 2021. According to the company’s earnings report, Gilead Sciences, Inc. (NASDAQ:GILD) generated revenues of $7.24 billion, down 2.39% year over year, but outperformed market consensus by over $0.60 million. The company reported earnings per share of $0.69, missing EPS estimates by $0.92.

This April, Piper Sandler analyst Do Kim raised his price target on Gilead Sciences, Inc. (NASDAQ:GILD) to $72 from $71 and maintained a Neutral rating on the shares.

Gilead Sciences, Inc. (NASDAQ:GILD) is rising in popularity among analysts and investor circles alike. At the close of Q4 2021, 54 hedge funds held stakes in Gilead Sciences, Inc. (NASDAQ:GILD). The total value of these stakes amounted to more than $2.36 billion, up from $1.75 billion in Q3 2021 with 55 positions.

Here is what ClearBridge Investments had to say about Gilead Sciences, Inc. (NASDAQ:GILD) in its fourth-quarter 2021 investor letter:

“Other pharma companies are providing solutions as well. Biopharmaceutical company Gilead Sciences’ remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication administered by intravenous infusion; it can shorten the time to recovery in hospitalized patients and reduce the risk of hospitalization and death in non-hospitalized patients.”

You can also take a look at 10 Best Tech Stocks To Buy Now According To Billionaire Laffont and 10 Best Stocks To Buy Now According To Quant Billionaires.

Follow Insider Monkey on Twitter